Newriver Reit (NRR) Stock Rating Reaffirmed by Liberum Capital

Share on StockTwits

Liberum Capital reissued their buy rating on shares of Newriver Reit (LON:NRR) in a report published on Tuesday morning.

Other equities research analysts also recently issued research reports about the company. Peel Hunt reaffirmed an add rating on shares of Newriver Reit in a report on Wednesday, November 21st. HSBC raised Newriver Reit to a buy rating in a report on Wednesday, January 2nd. Finally, Barclays dropped their target price on Newriver Reit from GBX 260 ($3.40) to GBX 250 ($3.27) and set an equal weight rating for the company in a report on Friday, February 15th. Two research analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. The company currently has a consensus rating of Buy and a consensus price target of GBX 302.50 ($3.95).

Shares of Newriver Reit stock opened at GBX 221.70 ($2.90) on Tuesday. Newriver Reit has a 1 year low of GBX 192.40 ($2.51) and a 1 year high of GBX 308.50 ($4.03). The firm has a market cap of $668.66 million and a price-to-earnings ratio of 35.19. The company has a debt-to-equity ratio of 59.37, a current ratio of 1.08 and a quick ratio of 1.08.

Newriver Reit Company Profile

NewRiver REIT plc (?NewRiver') is a leading Real Estate Investment Trust specializing in buying, managing, developing and recycling convenience-led, community-focused retail and leisure assets throughout the UK. Our £1.4 billion portfolio covers over 9 million sq ft and comprises 34 community shopping centres, 21 conveniently located retail parks and over 600 community pubs.

Featured Story: Net Asset Value

Analyst Recommendations for Newriver Reit (LON:NRR)

Receive News & Ratings for Newriver Reit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Newriver Reit and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Reviewing Blue Calypso  & Puxin
Reviewing Blue Calypso & Puxin
Wingstop  Hits New 52-Week High at $80.72
Wingstop Hits New 52-Week High at $80.72
$86.75 Million in Sales Expected for PTC Therapeutics, Inc.  This Quarter
$86.75 Million in Sales Expected for PTC Therapeutics, Inc. This Quarter
Q4 2020 Earnings Forecast for Childrens Place Inc  Issued By Wedbush
Q4 2020 Earnings Forecast for Childrens Place Inc Issued By Wedbush
3D Systems  Downgraded to D at TheStreet
3D Systems Downgraded to D at TheStreet
Legg Mason Inc Forecasted to Earn FY2020 Earnings of $2.70 Per Share
Legg Mason Inc Forecasted to Earn FY2020 Earnings of $2.70 Per Share


 
© 2006-2019 Zolmax.